Advertisement · 728 × 90
#
Hashtag
#Fiasp
Advertisement · 728 × 90
Preview
Medicine shortages

List of medicine shortages issued by #HPRA 5.9.25 #SpeirGorm

#iredoc FYI - insulins x 2 noted:

#Apidra
and
#Fiasp 100 units / mL #FlexTouch solution for injection in pre-filled pen

www.hpra.ie/find-a-medic...

0 0 0 0
Original post on social.hackerspace.pl

The Warm Days are here, so I guess by now the experiment is conclusive: mixing 1:1 #insulin #FIASP with something else (in my case, liprolog) still gives you faster action, but generally no site blockages during the 3-4 days I keep the site and tubing. Pure fiasp could result in a blockage […]

0 0 0 0
Original post on toot.community

I contacted my #endocrinologist about potentially using #fiasp in my #Tandem #tslim #insulinpump to help mitigate the issues I have balancing bolus response times & unpredictable #gastroparesis occurrence & duration. She’s not outright opposed which is nice, but she mentioned a different pump […]

0 0 0 0
Original post on toot.community

Attn: #T1D folks.

Have you any experience with #fiasp, particularly as used in an #insulin pump? How does it compare to #humalog or #novolog?

I take #novolog via my #tandem #tslim, but I’m finding it increasingly difficult to control my BG as my #gastroparesis grows more erratic over time. I’m […]

0 1 1 0

Here we go again. #Fiasp back order on Fiasp, offering us partial script for 100 and then want another 100 co-pay for the rest of the script. There isn’t $35 insulin. #T1D #disbetes my poor kiddo

2 1 0 0
Image showing two insulin FlexTouch® pens: the top pen is labeled Tresiba® (insulin degludec injection) with a green dosage selector, and the bottom pen is labeled Fiasp® (insulin aspart injection) with a red dosage selector, both designed for single-patient use.

Image showing two insulin FlexTouch® pens: the top pen is labeled Tresiba® (insulin degludec injection) with a green dosage selector, and the bottom pen is labeled Fiasp® (insulin aspart injection) with a red dosage selector, both designed for single-patient use.

Novo Nordisk plans to reduce U.S. list prices for its insulin products, Tresiba® and Fiasp®, by over 70% starting January 1, 2026. This move aims to improve insulin affordability and streamline product offerings.

jcst2d.com/index.php?vi...

#NovoNordisk #InsulinPrices #DiabetesCare #Tresiba #Fiasp

0 0 1 0